Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Public Health Regulatory Systems Strengthening - U01 Clinical Trials Not Allowed
The purpose of the Public Health Regulatory Systems Strengthening NOFO is to partner with the Organization for Economic Co-Operation and Development (OECD), primarily to address the growing threat of illicit trade in health products (drugs, vaccines, medical devices, food) through the development of
a whole-of-governments approach that relies on targeted, risk based, and efficient data driven models.
The data will be used to develop mitigation strategies and potential regulatory and enforcement solutions that address substandard, misleading, and falsified food and medical products sold both in informal markets and through legitimate channels and raise the profile and awareness of this issue within the global community.
The proposed cooperative agreement will also include work on other FDA public health topics of interest, including, but not limited to, addressing mis- and dis-information; strengthening regulatory frameworks by advancing health equity; promoting the use of good regulatory practices to develop regulations that are efficient, transparent, modern, and based on science and risk principles; and enhancing patient engagements in product development and quality of care.
The data will be used to develop mitigation strategies and potential regulatory and enforcement solutions that address substandard, misleading, and falsified food and medical products sold both in informal markets and through legitimate channels and raise the profile and awareness of this issue within the global community.
The proposed cooperative agreement will also include work on other FDA public health topics of interest, including, but not limited to, addressing mis- and dis-information; strengthening regulatory frameworks by advancing health equity; promoting the use of good regulatory practices to develop regulations that are efficient, transparent, modern, and based on science and risk principles; and enhancing patient engagements in product development and quality of care.
Agency: Department of Health and Human Services
Office: Food and Drug Administration
Estimated Funding: $150,000
Office: Food and Drug Administration
Estimated Funding: $150,000
Obtain Full Opportunity Text:
Link to Opportunity in SAMS Overseas
Additional Information of Eligibility:
Only the following organization is eligible to apply: Eligible Organizations The Organization for Economic Cooperation and Development (OECD) Foreign Institutions Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are eligible to apply.
Foreign components, as defined in the HHS Grants Policy Statement, are allowed.
Full Opportunity Web Address:
https://mygrants.servicenowservices.com/overseas?id=overseas_form&table=x_g_usd4_o_grant_funding_opportunity&sys_id=e75d90141b5f39103965a71de54bcb26&view=Default
Contact:
Agency Email Description:
Work
Agency Email:
Date Posted:
2023-12-20
Application Due Date:
Archive Date:
2024-03-30
Social Entrepreneurship
Spotlight
Partnerships in Social Enterprises Can Increase Social Impact
Chief executive of HCT, Dai Powell, shares the experiences and practical lessons he learned along the way when teaming up with Ealing Community Transport to deliver site transport during the Olympic Park construction.
Learn How to Identify and Avoid Grant Scams
